AP NEWS

Infectious Disease Disease & Epidemiology Overview, 2018 Featuring Merck, Gilead, Novavax & Johnson & Johnson - ResearchAndMarkets.com

December 18, 2018

DUBLIN--(BUSINESS WIRE)--Dec 18, 2018--The “Infectious Disease - Disease & Epidemiology Overview” report from Decision Resources Group has been added to ResearchAndMarkets.com’s offering.

This report provides a disease market overview for each indication and global epidemiology overviews for each indication.

The Infectious Disease & Epidemiology Overview report provides disease market overviews and global epidemiology overviews for 10 indications in the Infectious Disease therapy area: Clostridium Difficile Infection, Hospital-Treated Gram-Negative Infections, Methicillin-Resistant Staphylococcus Aureus Infections, Sepsis, Emerging Vaccines, Cytomegalovirus (CMV), Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus and Respiratory Syncytial Virus Disease.

The disease market overviews include information such as market size forecasts, prevailing treatment trend analysis and predictions, key areas of unmet need, current and emerging therapies, physician (KOL) insights, clinical pipeline analysis, and more, for each indication. The global epidemiology overviews provide insights including global diagnosed prevalence, diagnosed prevalence by region, 10-year diagnosed prevalence growth forecast, relative sizes of the factors contributing to the trend in prevalent cases, and more, for each indication.

Key Topics Covered:

About the Analyst About the analyst’s Epidemiology Disease Landscape and Insight Overview Epidemiology Overview

Companies Mentioned

Merck Gilead Novavax Johnson & Johnson

For more information about this report visit https://www.researchandmarkets.com/research/998qr4/infectious?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181218005296/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infectious Diseases Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/18/2018 03:58 AM/DISC: 12/18/2018 03:58 AM

http://www.businesswire.com/news/home/20181218005296/en

AP RADIO
Update hourly